A 12-week regimen of caloric restriction improves levels of adipokines and pro-inflammatory cytokines in Korean women with BMIs greater than 23 kg/m 2

Inflammation Research

Volumn 59, Issue 5, 2010, Pages 399-405

  Lee, In Seok ^a   Shin, Gina ^a   Choue, Ryowon ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Adipokines; Calorie restriction; Fat mass; Korean; Pro inflammatory cytokines

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; GAMMA INTERFERON; LEPTIN; LIPID; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY MASS; CALORIC RESTRICTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KOREA; LIPID BLOOD LEVEL; OBESITY; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOKINES; ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ASIAN CONTINENTAL ANCESTRY GROUP; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; CALORIC RESTRICTION; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; KOREA; MIDDLE AGED; WEIGHT LOSS; YOUNG ADULT;

EID: 77953362376     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-0113-8     Document Type: Article

References (45)

1. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004;291:2847-2850
2. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 1998;41:1241-1248
3. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27:813-823
4. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523-1529
5. Zuliani G, Ranzini M, Guerra G, Rossi L, Munari MR, Zurlo A, et al. Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia. J Psychiatr Res. 2007;41:686-693
6. Suliman ME, Stenvinkel P. Contribution of inflammation to vascular disease in chronic kidney disease patients. Saudi J Kidney Dis Transpl. 2008;19:329-345
7. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89:2583-2589
8. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110: 1093-1103
9. Busso N, So A, Chobaz-Péclat V, Morard C, Martinez-Soria E, Talabot-Ayer D, et al. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol. 2002;168:875-882
10. Beltowski J. Adiponectin and resistin\new hormones of white adipose tissue. Med Sci Monit. 2003;9:RA55-61.
11. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307-312
12. Wasim H, Al-Daghri NM, Chetty R, McTernan PG, Barnett AH, Kumar S. Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians. Cardiovasc Diabetol. 2006;5:10.
13. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307:426-430 (Pubitemid 40139988)
14. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care. 2003; 26:2442-2450
15. Kappes A, Loffler G. Influences of ionomycin, dibutyryl-cyclo AMP and tumor necrosis factor alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipo-cytes. Hormone Metab Res. 2000;32:548-554
16. Masaki T, Chiba S, Tatsukawa H, Yasuda T, Noguchi H, Seike M, et al. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology. 2004;40:177-184
17. Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, et al. Adiponectin specifically increased tissue inhibitor of metalloprotenase-1 through interleukin-10 expression in human macrophages. Circulation. 2004;109:2046-2049
18. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun. 2004;323: 630-635
19. Hauner H. Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc. 2005;64:163-169
20. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab. 2004;30:13-19
21. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk developing type 2 diabetes mellitus. JAMA. 2001;286:327-334
22. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antmann EM, et al. Association between plasma levels of monocyte chemoattractant protein-1 and longterm clinical outcomes in patients with acute coronary syndromes. Circulation. 2003;107:690-695
23. Fernandes G. Progress in nutritional immunology. Immunol Res. 2008;40:244-261
24. Wang J, Laferrère B, Thornton JC, Pierson RN Jr, Pi-Sunyer FX. Regional subcutaneous-fat loss induced by caloric restriction in obese women. Obes Res. 2002;10:885-890
25. Martin CK, Heilbronn LK, de Jonge L, DeLany JP, Volaufova J, Anton SD, Redman LM, Smith SR, Ravussin E. Effect of calorie restriction on resting metabolic rate and spontaneous physical activity. Obesity 2007;15:2964-2973
26. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416-423
27. Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199:543-551
28. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350:2549-2557
29. Noakes M, Keogh JB, Foster PR, Clifton PM. Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. Am J Clin Nutr. 2005;81:1253-1254
30. Farnsworth E, Luscombe ND, Noakes M, Wittert G, Argyiou E, Clifton PM. Effect of a high-protein, energy-restricted diet on body composition, glycemic control, and lipid concentrations in overweight and obese hyperinsulinemic men and women. Am J Clin Nutr. 2003;781:31-39
31. Bimenya GS, Okot JK, Nangosa H, Anguma SA, Byarugaba W. Plasma cholesterol and related lipid levels of seemingly healthy public service employees in Kampala, Uganda. Afr Health Sci. 2006;6:139-144
32. Dvoráková-Lorenzová A, Suchánek P, Havel PJ, Stávek P, Karasová L, Valenta Z, et al. The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. Metabolism. 2006;55:359-365
33. Morgan K, Obici S, Rossetti L. Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J Biol Chem. 2004;279(30):31139-31148
34. Chearskul S, Delbridge E, Shulkes A, Proietto J, Kriketos A. Effect of weight loss and ketosis on postprandial cholecystokinin and free fatty acid concentrations. Am J Clin Nutr. 2008;87: 1238-1246
35. Grau AJ, Buggle F, Becher H, Werle E, Hacke W. The association of leukocyte count, fibrinogen and C reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res. 1996;82:245-255
36. Ford ES. Body mass index, diabetes and C-reactive protein among U.S. adults. Diabetes Care. 1999;22:1971-1977
37. Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, et al. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care. 2003;26:2383-2387
38. Konturek SJ, Konturek JW, Pawlik T, Brzozowski T. Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol. 2004;55:137-154
39. Konturek PC, Brzozowski T, Burnat G, Kwiecien S, Pawlik T, Hahn EG, et al. Role of brain-gut axis in healing of gastric ulcers. J Physiol Pharmacol. 2004;55:179-192 (Pubitemid 38450985)
40. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001;280:E745-51.
41. Zozulinka D, Majchrzak A, Sobieska M, Wiktorowicz K, Wierusz-Wysocka B. Serum interleukin-8 level is increased in diabetic patients. Diabetologia. 1999;42:117-118
42. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 2002;105:804-809
43. Monzillo LU, Hamdy O, Horton ES, Ledbury S, Mullooly C, Jarema C, et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res. 2003;11:1048-1054 (Pubitemid 41151581)
44. Kopp HP, Kopp CW, Festa A, Krzyzanowska K, Kriwanek S, Minar E, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003;23:1042-1047
45. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508-519